MBX
MBX Biosciences, Inc. Common Stock
NASDAQ: MBX · HEALTHCARE · BIOTECHNOLOGY
$30.22
+5.63% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$9 – $45
Volume
0.5M
MBX Biosciences, Inc. Common Stock (MBX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 7
Last 7 quarters
Avg EPS surprise
+13.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-4.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.9%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+13.4%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-23 | $-0.49 | +17.9% | $28.68 | $27.82 | -3.0% |
| 2025-11-06 | $-0.63 | +4.9% | $22.55 | $25.57 | +13.4% |
| 2025-08-07 | $-0.58 | +24.0% | $11.67 | $12.16 | +4.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.60 | $-0.49 | +17.9% | — | — |
| 2025-09-30 | $-0.66 | $-0.63 | +4.9% | — | — |
| 2025-06-30 | $-0.76 | $-0.58 | +24.0% | — | — |
| 2025-03-31 | $-0.77 | $-0.71 | +7.9% | — | — |
| 2024-12-31 | $-0.59 | $-0.47 | +19.8% | $222000.00 | — |
| 2024-09-30 | $-2.72 | $-2.78 | -2.3% | — | — |
| 2024-06-30 | $0.00 | $-11.47 | — | — | — |
Frequently asked questions
Has MBX Biosciences, Inc. Common Stock beaten earnings estimates?
MBX Biosciences, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 7 quarterly reports, with an average EPS surprise of +13.7% over the last 4 quarters.
How does MBX stock react to earnings?
MBX stock has moved an average of +4.9% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.